Time Sensitive News for Traders

XTLB - XTL Biopharmaceuticals Ltd.

Profile for XTL Biopharmaceuticals Ltd.  (XTLB) 
$ 0.1068   0.0268 (+33.50%) Volume: 1.35 m 3:58 PM EST Dec 1, 2008
After Hours:  $ 0.11   0.0032 (+3.00%) Volume: 1000 5:18 PM EST Dec 1, 2008
Business Description:
A biopharmaceutical company engaged in the acquisition and development of pharmaceutical products for the treatment of unmet medical needs, particularly the treatment of diabetic neuropathic pain and hepatitis C.
Address: 711 Executive Blvd., Suite Q, New York 10989
Telephone:
(845) 267-0707
Website:
www.xtlbio.com
Facsimile:
(845) 267-0926
Email:
IR@xtlbio.com
Details
CEO:
Ron Bentsur
Employees:
25
Market Cap:
3.13 m
Issue Type:
AD
Auditor: Kesselman & Kesselman
Last Audit: UQ
Indices: Biotechnology
Industry Classifications
Sector:
Healthcare
CIK:
0001023549
Industry: Drugs
NAICS: Pharmaceutical Preparation Manufacturing (325412)
QM ID: Biotechnology(515)
SIC: Pharmaceutical Preparations (2834)

Open a Brokerage Account and Start Trading Today!
100% Free Stock Trade. Trade stocks for free on Zecco.com. The Free Trading Community. www.zecco.com

TD Ameritrade

Scottrade

E*TRADE